The Toronto-headquartered wellness company started conducting sessions in 2021.

The company is a subsidiary of Burnaby-based psychedelics venture Filament Health Corp.

Study provides an overview of emerging enquiries at the intersection of the two subjects that involve the human mind.

The company has come up with a derivative of ibogaine, a psychoactive substance from an African shrub.

Toronto company seeks to come up with alternative way to administer psychedelic substances.

The Vancouver functional and psychedelic fungi company has applied for a Health Canada dealer’s licence.